| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.089 | 0.07 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |